GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov
Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an […]
Clinical Trials and Research Roundup | Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?
Introducing the Physicians for Civil Defense: Prominent Doctors Know #Ivermectin can Help Treat COVID-19: Will Anyone Listen?A group calling […]
Sanofi & GSK Vaccine Reagent Mistake Will Cost Hundreds of Millions & 4-5 Month Delay During Pandemic
An incredibly costly mistake will delay the Sanofi SA and GlaxoSmithKline PLC COVID-19 vaccine by several months, complicating plans by […]
Sanofi & Regeneron Phase III Lung Cancer Drug Trial Stopped Early Due to Significant Improvement in Overall Survival
Although Sanofi and Regeneron are not in the current PD-1/PD-L1 market mix they are scrambling to be with Libtayo (cemiplimab) […]
Regeneron & Sanofi Amend Phase II/III Kevzara COVID-19 Clinical Trial—Only Focus on Critical Patients
An Independent Data Monitoring Committee (IDMC) suggested that Regeneron and Sanofi only continue the ongoing Phase II/III clinical trial for […]
Sanofi & GSK Ink LOI to Commence COVID-19 Vaccine Collaboration: Finished Good Projected for 14+ Months Away
European pharmaceutical giants recently inked a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from […]
University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm
University of Buffalo (UB) and Roswell Park Comprehensive Cancer Center received the greenlight from the U.S. Food and Drug Administration […]
Regeneron & Sanofi Gear Up for Global Clinical Trial Targeting COVID-19 Symptoms
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi announced the partners have commenced a clinical program evaluating Kevzara® (sarilumab) in patients […]
Sanofi Backs Out of $1.7 Billion Deal With Lexicon Pharmaceuticals—Stock Drops 66%
Up to a $1.7 billion collaboration was terminated when Sanofi canceled an agreement with Lexicon Pharmaceuticals to develop Zynquista™ (sotagliflozin) after […]
SiteWatch: Up to 48 Years in Prison for Philippines Investigator Involved with Dengue Vaccine Sponsored by Sanofi Pasteur
Fatima Arkin of Science writes that a prominent pediatrician and investigator in the Philippines was indicted over the failed and […]
